“A clinical impact study of dermatologists’ use of the 23- or 35-gene expression profile tests to guide surgical excision and enhance management plan confidence” (2023) SKIN The Journal of Cutaneous Medicine, 7(2), p. s166. doi:10.25251/skin.7.supp.166.